Editas医药 EDIT 深 沪
等待开盘 10-31 09:30:00 美东时间
3.01
-0.030
-0.99%
华盛通- 最 高3.065
- 今 开3.00
- 成交量 118.62万股
- 最 低 2.94
- 昨 收 3.04
- 总市值 2.52亿
- 52周最高 4.5372
- 市盈率 静 --
- 换手率 1.42%
- 52周最低 0.9101
- 委 比 -52.21%
- 总股本 8371.29万
- 历史最高 99.95
- 量 比 0.45
- 振 幅 4.11%
- 历史最低 0.9101
- 每 手 1
- 风险率 0.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event.
10-27 22:38
快讯 | 美股基因编辑概念股盘前下挫，NTLA一度暴跌超60%
基因编辑公司 $Intellia Therapeutics (NTLA.US)$ 盘前一度暴跌超60%，消息面上，该公司宣布暂停其针对转甲状腺素蛋白淀粉样伴心肌...
10-27 20:17
HURRICANE ANNOUNCES MODEL REFRESH FOR SUNDECK 2690
ELKHART, Ind., Oct. 23, 2025 /PRNewswire/ -- Hurricane Boats, legendary innovator in versatile deck boat designs, announced today it has redesigned the classic, Yacht Series Hurricane SunDec...
10-24 00:17
FIRST CREDIT：请求复核GEM上市委员会的决定
FIRST CREDIT（08215）发布公告，根据GEM上市规则第四章，公司有权自发出除牌决定当日起七个营业日内（即2025年10月15日或之前）将除牌决定提...
10-23 08:20
深度｜诺奖背后生物技术公司力量迅速崛起，科学家创业有何秘诀？
在做科研的时候，一定是挑专业领域里最难的问题去攻克，而在创办企业的时候，应该要挑最容易的那部分去做，这样才最有可能将科研成果转化为实际的经济收益。 诺贝...
10-12 14:06
FIRST CREDIT：GEM上市委员会决定取消公司的上市地位
FIRST CREDIT（08215）发布公告，于2025年10月3日，公司接获联交所的函件，当中声明GEM上市委员会已决定根据GEM上市规则第9.14A 条取...
10-09 08:23
Editas Medicine To Deliver EDIT-401 Oral Presentation At European Society Of Gene And Cell Therapy Congress, October 7–10, 2025, In Seville, Spain
Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced an oral presentation at the upcoming European Society of Gene
10-06 21:05
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
Editas Medicine has announced an oral presentation at the October 7-10, 2025 European Society of Gene and Cell Therapy Congress in Seville, Spain. The presentation, titled "A transformative LDL-cholesterol–lowering in vivo CRISPR gene editing medicine," will be delivered by Linda Burkly, Ph.D., on October 9 at 5:00 p.m. CEST. Additionally, the company will participate in the H.C. Wainwright Genetic Medicines Virtual Conference on October 14 and t...
10-06 13:00
AEON CREDIT将于11月4日派发中期股息每股0.25港元
AEON CREDIT（00900）发布公告，将于2025年11月4日派发截至2025年8月31日止六个月的中期股息每股0.25港元。
09-30 12:37
